Emergent BioSolutions Inc. (LON:0IGA)

Emergent BioSolutions Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 9, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	424	414	98	489	1,727	3,478
Market Cap Growth	-16.22%	323.24%	-80.01%	-71.69%	-50.34%	65.40%
Enterprise Value	735	834	720	1,174	2,086	3,849
Last Close Price	8.02	7.47	1.88	9.59	33.34	59.37
PE Ratio	7.51	-	-	-	10.65	15.53
PS Ratio	0.72	0.50	0.12	0.53	1.32	3.01
PB Ratio	0.98	1.07	0.19	0.43	1.45	3.28
P/TBV Ratio	4.39	-	1.51	1.34	2.99	9.18
P/FCF Ratio	406.89	14.47	-	-	24.34	12.02
P/OCF Ratio	43.82	8.82	-	-	7.30	8.85
EV/Sales Ratio	1.27	1.00	0.87	1.26	1.59	3.33
EV/EBITDA Ratio	4.57	19.55	-	90.08	5.60	8.63
EV/EBIT Ratio	8.11	-	-	-	7.32	10.53
EV/FCF Ratio	705.76	29.17	-	-	29.39	13.30
Debt / Equity Ratio	1.15	1.40	1.35	1.03	0.54	0.64
Debt / EBITDA Ratio	3.05	12.66	-	90.85	1.72	1.50
Debt / FCF Ratio	479.29	18.89	-	-	9.13	2.34
Asset Turnover	0.54	0.65	0.42	0.37	0.61	0.61
Inventory Turnover	1.19	2.29	2.34	2.38	3.01	2.70
Quick Ratio	2.89	1.56	0.47	0.66	2.29	2.22
Current Ratio	5.77	3.69	1.04	0.99	3.40	3.11
Return on Equity (ROE)	13.91%	-33.67%	-74.67%	-14.11%	14.35%	24.12%
Return on Assets (ROA)	5.27%	-2.03%	-4.21%	-2.23%	8.26%	11.98%
Return on Invested Capital (ROIC)	9.09%	-4.22%	-9.40%	-5.36%	15.27%	21.13%
Return on Capital Employed (ROCE)	9.40%	-4.30%	-14.30%	-5.60%	14.90%	20.00%
Earnings Yield	13.32%	-36.80%	-610.73%	-35.91%	9.39%	6.44%
FCF Yield	0.25%	6.91%	-207.11%	-25.44%	4.11%	8.32%
Buyback Yield / Dilution	-6.86%	-3.52%	-2.20%	7.39%	-0.56%	-2.67%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.